The disease-specific measure was the Pediatric Migraine Disability Assessment Score (PedMIDAS). This is a validated instrument that measures the impact of headache-related quality of life in terms of days in the previous 3-month period where headache has had a total or partial impact on school or home life.17 The generic measure was the Pediatric Quality of Life Inventory (PedsQL4), the most widely used generic measure in paediatric practice.18 It has been validated in UK school children,19 and also for use in headache.20
How this fits in
Although it is recognised that headache has a significant impact on the adult population, the prevalence and impact in children is not well recognised. This demonstrates a considerable unmet need of headache sufferers in a paediatric population, in terms of both headache-related and generic quality of life. As headache sits within a biopsychosocial framework, the direction of causality that is described remains contested.